Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants

NCT00425737 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: Rotarix

Sponsor

GlaxoSmithKline